DCF — FRANKLIN MEDICAL CENTER
Enterprise Value: $-65.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-65.9M
Enterprise Value
$-20.9M
PV of Cash Flows
$-45.0M
PV of Terminal Value
$-72.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $42.4M | $-4.1M | -10.0% | $-5.9M | $-5.3M |
| Year 2 | $43.7M | $-3.8M | -9.0% | $-5.6M | $-4.6M |
| Year 3 | $45.0M | $-3.4M | -8.0% | $-5.3M | $-4.0M |
| Year 4 | $46.3M | $-3.3M | -7.0% | $-5.3M | $-3.6M |
| Year 5 | $47.7M | $-3.3M | -7.0% | $-5.3M | $-3.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-65.9M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$41.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.10124475842239163
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5